+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biochips Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4744574
  • Report
  • October 2018
  • Region: Global
  • 235 pages
  • Allied Analytics LLP

Enquire about COVID-19 updates for this product.

Enquire Now
Biochips Market Overview:

Biochip is a miniaturized medical device, which performs several biochemical reactions. This device is a collection of microarrays or micro-test strips that are arranged on the surface of chip, and are meant to perform multiple tests simultaneously. Biochip is extremely small in size ranging from 2 inches to 12 inches. These chips can perform various biotechnology applications such as decoding genes and searching for contaminations in the sample in a few seconds.

The global biochips market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025 at a CAGR of 11.2% from 2018 to 2025. Factors such as rise in prevalence of various life-threatening diseases increases the demand for disease diagnostics, which in turn drives the growth of the global biochips market. Moreover, rise in adoption of personalized medicines and presence of large geriatric population boost the market growth. However, lack of knowledge related to biochips and their high cost of hamper the market growth. Conversely, huge untapped potential in the emerging countries, such as China and India, and rise in R&D investment as well as government funding are expected to offer lucrative opportunities to the market players.

The global biochips market is segmented based on product, application, end user, and region. Depending on product, the market is divided into DNA chip, protein chip, lab-on-a-chip, and others. By application, it is categorized into drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and other applications. On the basis of end user, it is classified into biotechnology & pharmaceutical companies, hospitals & diagnostics centers, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Biochips Market:

The study provides an in-depth analysis of the global biochips market along with current trends and future estimations from 2018 to 2025 to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Biochips Key market segments:

By Product

DNA Chip
Protein Chip
Lab-on-a-chip
Others

By Application

Drug Discovery & Development
Disease Diagnostics
Genomics
Proteomics
Agriculture
Others

By End User

Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostics Centers
Academic & Research Institutes
Others

By Region

North America
U.S.
Canada
Mexico

Europe
Germany
France
UK
Italy
Spain
Rest of Europe

Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific

LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

bioMérieux SA
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche AG
Fluidigm Corporation
HORIBA, Ltd.
Illumina, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Micronit Microfluidics BV
OriGene Technologies, Inc.
ANALIS sa/nv
AMS Alliance
Dynamic Biosensors GmbH
Note: Product cover images may vary from those shown
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of key players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

Chapter 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017 (%)
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the incidence life threatening disorders
3.4.1.2. Rise in geriatric population
3.4.1.3. High demand of personalized medicines
3.4.1.4. Large number of biochips applications
3.4.2. Restraints
3.4.2.1. High cost of biochips
3.4.2.2. Lack of awareness in developing countries
3.4.3. Opportunity
3.4.3.1. Untapped market opportunities in the developing regions
3.4.4. Impact analyses

Chapter 4: BIOCHIPS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast, by product
4.2. DNA chip
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Protein chip
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Lab-on-chip
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Others
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

Chapter 5: BIOCHIPS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by revenue
5.2. Drug discovery and development
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Disease diagnostics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Genomics
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Proteomics
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Agriculture
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
5.7. Other applications
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country

Chapter 6: BIOCHIPS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. BIoTechnology and pharmaceutical companies
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Hospitals & diagnostics centers
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Academic and research institutes
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Other end users
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

Chapter 7: BIOCHIPS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. market size and forecast, by product
7.2.2.1.2. U.S. market size and forecast, by application
7.2.2.1.3. U.S. market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada market size and forecast, by product
7.2.2.2.2. Canada market size and forecast, by application
7.2.2.2.3. Canada market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico market size and forecast, by product
7.2.2.3.2. Mexico market size and forecast, by application
7.2.2.3.3. Mexico market size and forecast, by end user
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe biochips market, by country
7.3.2.1. Germany
7.3.2.1.1. Germany market size and forecast, by product
7.3.2.1.2. Germany market size and forecast, by application
7.3.2.1.3. Germany market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. France market size and forecast, by product
7.3.2.2.2. France market size and forecast, by application
7.3.2.2.3. France market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. UK market size and forecast, by product
7.3.2.3.2. UK market size and forecast, by application
7.3.2.3.3. UK market size and forecast, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy market size and forecast, by product
7.3.2.4.2. Italy market size and forecast, by application
7.3.2.4.3. Italy market size and forecast, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain market size and forecast, by product
7.3.2.5.2. Spain market size and forecast, by application
7.3.2.5.3. Spain market size and forecast, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe market size and forecast, by product
7.3.2.6.2. Rest of Europe market size and forecast, by application
7.3.2.6.3. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan market size and forecast, by product
7.4.2.1.2. Japan market size and forecast, by application
7.4.2.1.3. Japan market size and forecast, by end user
7.4.2.2. China
7.4.2.2.1. China market size and forecast, by product
7.4.2.2.2. China market size and forecast, by application
7.4.2.2.3. China market size and forecast, by end user
7.4.2.3. India
7.4.2.3.1. India market size and forecast, by product
7.4.2.3.2. India market size and forecast, by application
7.4.2.3.3. India market size and forecast, by end user
7.4.2.4. Australia
7.4.2.4.1. Australia market size and forecast, by product
7.4.2.4.2. Australia market size and forecast, by application
7.4.2.4.3. Australia market size and forecast, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea market size and forecast, by product
7.4.2.5.2. South Korea market size and forecast, by application
7.4.2.5.3. South Korea market size and forecast, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application
7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil market size and forecast, by product
7.5.2.1.2. Brazil market size and forecast, by application
7.5.2.1.3. Brazil market size and forecast, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia market size and forecast, by product
7.5.2.2.2. Saudi Arabia market size and forecast, by application
7.5.2.2.3. Saudi Arabia market size and forecast, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Arica market size and forecast, by product
7.5.2.3.2. South Arica market size and forecast, by application
7.5.2.3.3. South Arica market size and forecast, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA market size and forecast, by product
7.5.2.4.2. Rest of LAMEA market size and forecast, by application
7.5.2.4.3. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user

Chapter 8: COMPANY PROFILES
8.1. bioMrieux S.A.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.2. Bio-Rad Laboratories, Inc.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. F. Hoffmann-La Roche Ltd.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Fluidigm Corporation
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Illumina, Inc.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. HORIBA, Ltd.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. PerkinElmer, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product Portfolio
8.7.5. Business performance
8.8. QIAGEN N.V.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Randox Laboratories Ltd.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.10. Thermo Fisher Scientific Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

List Of Tables
Table 01. Global Biochips Market, By Product, 2017-2025 ($Million)
Table 02. Dna Chip Market, By Region, 2017-2025 ($Million)
Table 03. Protein Chip Market, By Region, 2017-2025 ($Million)
Table 04. Lab-On-Chip Market, By Region, 2017-2025 ($Million)
Table 05. Others Biochips Market, By Region, 2017-2025 ($Million)
Table 06. Global Biochips Market Revenue, By Application, 2017-2025 ($Million)
Table 07. Biochips Market For Drus Discovery And Development, By Region, 2017-2025 ($Million)
Table 08. Biochips Market For Disease Diagnostics, By Region, 2017-2025 ($Million)
Table 09. Biochips Market For Genomics, By Region, 2017-2025 ($Million)
Table 10. Biochips Market For Proteomics, By Region, 2017-2025 ($Million)
Table 11. Biochips Market For Agriculture, By Region, 2017-2025 ($Million)
Table 12. Biochips Market For Other Applications, By Region, 2017-2025 ($Million)
Table 13. Global Biochips Market Revenue, By End User, 2017-2025 ($Million)
Table 14. Biochips Market For BIoTechnology And Pharmaceutical Companies, By Region, 2017-2025 ($Million)
Table 15. Biochips Market For Hospitals & Diagnostics Centers, By Region, 2017-2025 ($Million)
Table 16. Biochips Market For Academic And Research Institutes, By Region, 2017-2025 ($Million)
Table 17. Biochips Market For Other End Users, By Region, 2017-2025 ($Million)
Table 18. Biochips Market, By Region, 2017-2025 ($Million)
Table 19. North America Biochips Market, By Country, 2017-2025 ($Million)
Table 20. U.S. Biochips Market, By Product, 2017-2025 ($Million)
Table 21. U.S. Biochips Market, By Application, 2017-2025 ($Million)
Table 22. U.S. Biochips Market, By End User, 2017-2025 ($Million)
Table 23. Canada Biochips Market, By Product, 2017-2025 ($Million)
Table 24. Canada Biochips Market, By Application, 2017-2025 ($Million)
Table 25. Canada Biochips Market, By End User, 2017-2025 ($Million)
Table 26. Mexico Biochips Market, By Product, 2017-2025 ($Million)
Table 27. Mexico Biochips Market, By Application, 2017-2025 ($Million)
Table 28. Mexico Biochips Market, By End User, 2017-2025 ($Million)
Table 29. North America Biochips Market, By Product, 2017-2025 ($Million)
Table 30. North America Biochips Market, By Application, 2017-2025 ($Million)
Table 31. North America Biochips Market, By End User, 2017-2025 ($Million)
Table 32. Europe Biochips Market, By Country, 2017-2025 ($Million)
Table 33. Germany Biochips Market, By Product, 2017-2025 ($Million)
Table 34. Germany Biochips Market, By Application, 2017-2025 ($Million)
Table 35. Germany Biochips Market, By End User, 2017-2025 ($Million)
Table 36. France Biochips Market, By Product, 2017-2025 ($Million)
Table 37. France Biochips Market, By Application, 2017-2025 ($Million)
Table 38. France Biochips Market, By End User, 2017-2025 ($Million)
Table 39. UK Biochips Market, By Product, 2017-2025 ($Million)
Table 40. UK Biochips Market, By Application, 2017-2025 ($Million)
Table 41. UK Biochips Market, By End User, 2017-2025 ($Million)
Table 42. Italy Biochips Market, By Product, 2017-2025 ($Million)
Table 43. Italy Biochips Market, By Application, 2017-2025 ($Million)
Table 44. Italy Biochips Market, By End User, 2017-2025 ($Million)
Table 45. Spain Biochips Market, By Product, 2017-2025 ($Million)
Table 46. Spain Biochips Market, By Application, 2017-2025 ($Million)
Table 47. Spain Biochips Market, By End User, 2017-2025 ($Million)
Table 48. Rest Of Europe Biochips Market, By Product, 2017-2025 ($Million)
Table 49. Rest Of Europe Biochips Market, By Application, 2017-2025 ($Million)
Table 50. Rest Of Europe Biochips Market, By End User, 2017-2025 ($Million)
Table 51. Europe Biochips Market, By Product, 2017-2025 ($Million)
Table 52. Europe Biochips Market, By Application, 2017-2025 ($Million)
Table 53. Europe Biochips Market, By End User, 2017-2025 ($Million)
Table 54. Asia-Pacific Biochips Market, By Country, 2017-2025 ($Million)
Table 55. Japan Biochips Market, By Product, 2017-2025 ($Million)
Table 56. Japan Biochips Market, By Application, 2017-2025 ($Million)
Table 57. Japan Biochips Market, By End User, 2017-2025 ($Million)
Table 58. China Biochips Market, By Product, 2017-2025 ($Million)
Table 59. China Biochips Market, By Application, 2017-2025 ($Million)
Table 60. China Biochips Market, By End User, 2017-2025 ($Million)
Table 61. India Biochips Market, By Product, 2017-2025 ($Million)
Table 62. India Biochips Market, By Application, 2017-2025 ($Million)
Table 63. India Biochips Market, By End User, 2017-2025 ($Million)
Table 64. Australia Biochips Market, By Product, 2017-2025 ($Million)
Table 65. Australia Biochips Market, By Application, 2017-2025 ($Million)
Table 66. Australia Biochips Market, By End User, 2017-2025 ($Million)
Table 67. South Korea Biochips Market, By Product, 2017-2025 ($Million)
Table 68. South Korea Biochips Market, By Application, 2017-2025 ($Million)
Table 69. South Korea Biochips Market, By End User, 2017-2025 ($Million)
Table 70. Rest Of Asia-Pacific Biochips Market, By Product, 2017-2025 ($Million)
Table 71. Rest Of Asia-Pacific Biochips Market, By Application, 2017-2025 ($Million)
Table 72. Rest Of Asia-Pacific Biochips Market, By End User, 2017-2025 ($Million)
Table 73. Asia-Pacific Biochips Market, By Product, 2017-2025 ($Million)
Table 74. Asia-Pacific Biochips Market, By Application, 2017-2025 ($Million)
Table 75. Asia-Pacific Biochips Market, By End User, 2017-2025 ($Million)
Table 76. LAMEA Biochips Market, By Country, 2017-2025 ($Million)
Table 77. Brazil Biochips Market, By Product, 2017-2025 ($Million)
Table 78. Brazil Biochips Market, By Application, 2017-2025 ($Million)
Table 79. Brazil Biochips Market, By End User, 2017-2025 ($Million)
Table 80. Saudi Arabia Biochips Market, By Product, 2017-2025 ($Million)
Table 81. Saudi Arabia Biochips Market, By Application, 2017-2025 ($Million)
Table 82. Saudi Arabia Biochips Market, By End User, 2017-2025 ($Million)
Table 83. South Arica Biochips Market, By Product, 2017-2025 ($Million)
Table 84. South Arica Biochips Market, By Application, 2017-2025 ($Million)
Table 85. South Arica Biochips Market, By End User, 2017-2025 ($Million)
Table 86. Rest Of LAMEA Biochips Market, By Product, 2017-2025 ($Million)
Table 87. Rest Of LAMEA Biochips Market, By Application, 2017-2025 ($Million)
Table 88. Rest Of LAMEA Biochips Market, By End User, 2017-2025 ($Million)
Table 89. LAMEA Biochips Market, By Product, 2017-2025 ($Million)
Table 90. LAMEA Biochips Market, By Application, 2017-2025 ($Million)
Table 91. LAMEA Biochips Market, By End User, 2017-2025 ($Million)
Table 92. Biomrieux S.A.: Company Snapshot
Table 93. Biomrieux S.A.: Operating Segments
Table 94. Biomrieux S.A.: Product Portfolio
Table 95. Bio-Rad Laboratories, Inc.: Company Snapshot
Table 96. Bio-Rad Laboratories, Inc.: Business Segments
Table 97. Bio-Rad Laboratories, Inc.: Product Portfolio
Table 98. Roche: Company Snapshot
Table 99. Roche: Operating Segments
Table 100. Roche: Product Portfolio
Table 101. Fluidigm Corporation: Company Snapshot
Table 102. Fluidigm Corporation: Product Portfolio
Table 103. Illumina, Inc.: Company Snapshot
Table 104. Illumina, Inc.: Operating Segments
Table 105. Illumina, Inc.: Product Portfolio
Table 106. Horiba: Company Snapshot
Table 107. Horiba: Business Segments
Table 108. Horiba: Product Portfolio
Table 109. Perkinelmer, Inc.: Company Snapshot
Table 110. Perkinelmer, Inc.: Operating Segments
Table 111. Perkinelmer, Inc.: Product Portfolio
Table 112. Qiagen N.V.: Company Snapshot
Table 113. Qiagen N.V.: Product Portfolio
Table 114. Randox Laboratories Ltd.: Company Snapshot
Table 115. Randox Laboratories Ltd.: Divisions
Table 116. Randox Laboratories Ltd.: Product Portfolio
Table 117. Thermo Fisher Scientific Inc.: Company Snapshot
Table 118. Thermo Fisher Scientific Inc.: Operating Segments
Table 119. Randox Laboratories Ltd.: Product Portfolio

List of Figures
Figure 01. Global Biochips Market Segmentation
Figure 02. Top Investment Pockets
Figure 03. Top Player Positioning, 2017
Figure 04. Number Of New Cases Of Cancer Per 100,000 People, 2018
Figure 05. Impact Analyses
Figure 06. Comparative Country Analysis Of Dna Chip Market, 2017 & 2025 (%)
Figure 07. Comparative Country Analysis Of Protein Chip Market, 2017 & 2025 (%)
Figure 08. Comparative Country Analysis Of Lab-On-Chip Market, 2017 & 2025 (%)
Figure 09. Comparative Country Analysis Of Other Biochips Market, 2017 & 2025 (%)
Figure 10. Comparative Country Analysis Of Biochips Market For Drug Discovery And Development, 2017 & 2025 (%)
Figure 11. Comparative Country Analysis Of Biochips Market For Disease Diagnostics, 2017 & 2025 (%)
Figure 12. Comparative Country Analysis Of Biochips Market For Genomics, 2017 & 2025 (%)
Figure 13. Comparative Country Analysis Of Biochips Market For Proteomics, 2017 & 2025 (%)
Figure 14. Comparative Country Analysis Of Biochips Market For Agriculture, 2017 & 2025 (%)
Figure 15. Comparative Country Analysis Of Biochips Market For Other Applications, 2017 & 2025 (%)
Figure 16. Comparative Country Analysis Of Biochips Market For BIoTechnology & Pharmaceutical Companies, 2017 & 2025 (%)
Figure 17. Comparative Country Analysis Of Biochips Market For Hospitals And Diagnostics Centers, 2017 & 2025 (%)
Figure 18. Comparative Country Analysis Of Biochips Market For Academic And Research Institutes, 2017 & 2025 (%)
Figure 19. Comparative Country Analysis Of Biochips Market For Other End Users, 2017 & 2025 (%)
Figure 20. Biomrieux S.A.: Net Sales, 2015-2017 ($Million)
Figure 21. Biomrieux S.A.: Net Sales Share By Segment, 2017 (%)
Figure 22. Biomrieux S.A.: Net Sales Share By Geography, 2017 (%)
Figure 23. Bio-Rad Laboratories, Inc.: Net Sales, 2015-2017 ($Million)
Figure 24. Bio-Rad Laboratories, Inc.: Revenue Share, By Segment, 2017 (%)
Figure 25. Bio-Rad Laboratories, Inc.: Revenue Share, By Geography, 2017 (%)
Figure 26. Roche: Net Sales, 2015-2017 ($Million)
Figure 27. Roche: Revenue Share By Segment, 2017 (%)
Figure 28. Roche: Revenue Share By Geography, 2017 (%)
Figure 29. Fluidigm Corporation: Net Sales, 2015-2017 ($Million)
Figure 30. Fluidigm Corporation: Revenue Share, By Geography, 2017 (%)
Figure 31. Illumina, Inc.: Net Sales, 2015-2017 ($Million)
Figure 32. Illumina, Inc.: Net Sales, By Segment, 2017 (%)
Figure 33. Illumina, Inc.: Net Sales, By Geography, 2017 (%)
Figure 34. Horiba: Net Sales, 2015-2017 ($Million)
Figure 35. Horiba: Net Sales, By Segment, 2017 (%)
Figure 36. Horiba: Net Sales, By Geography, 2017 (%)
Figure 37. Perkinelmer, Inc.: Net Sales, 2015-2017 ($Million)
Figure 38. Perkinelmer, Inc.: Revenue Share By Segment, 2017 (%)
Figure 39. Perkinelmer, Inc.: Revenue Share By Geography, 2017 (%)
Figure 40. Qiagen N.V.: Net Sales, 2015-2017 ($Million)
Figure 41. Qiagen N.V.: Revenue Share By Product Segment, 2017 (%)
Figure 42. Qiagen N.V.: Revenue Share By Geography, 2017 (%)
Figure 43. Thermo Fisher Scientific Inc.: Revenue, 2015-2017 ($Million)
Figure 44. Thermo Fisher Scientific Inc.: Revenue Share By Segment, 2017 (%)
Figure 45. Thermo Fisher Scientific Inc.: Revenue Share By Geography, 2017 (%)
Note: Product cover images may vary from those shown
According to this report titled, Biochips Market, by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025,' the market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025, registering a CAGR of 11.2% from 2018 to 2025.

Biochip is a miniaturized integrated medical device, which performs numerous biological or biochemical reactions simultaneously. It is extremely small in size, and consists of microscope slide, which is manufactured of glass, nylon, or silicon. It is a collection of microarrays, which are arranged on a solid substrate and perform functions such as decoding genes, screening of large number of biological analytes, and finding contaminations in a few seconds.

The biochips market is anticipated to exhibit significant growth in the near future, owing to factors such as rise in prevalence of life-threatening disorders, surge in number of aged people who are susceptible to cancer, increase in applications of biochips, and high demand for personalized medicines. However, high cost of biochip products and lack of knowledge about biochips hinder the market growth. On the contrary, increase in R&D investments as well as government funding and high growth potential in developing regions are expected to provide numerous opportunities for the market growth.

The DNA chip segment accounted for the largest share in 2017, owing to high availability of DNA chips as compared to other products. However, the protein chip segment is expected to grow at the high CAGR from 2018 to 2025.

The drug discovery & development segment led the global biochips market in 2017, and is expected to maintain this trend during the forecast period. On the other hand, disease diagnostics segment is anticipated to record the highest CAGR from 2018 to 2025.

The utilization rate of biochips in biotechnology and pharmaceutical companies was high in 2017. However, the academic and research institutes segment is expected to grow at a CAGR of 13.5% during the forecast period.

Key findings of the Biochips Market:

The lab-on-a-chip segment accounted for nearly 37% share of the global biochips market in 2017.
The genomics segment is expected to grow at a CAGR of 10.6% from 2018 to 2025.
The hospitals & diagnostics centers segment accounted for around one-fourth share of the global market in 2017.
Europe accounted for more than one-fourth share of the global market in 2017.
LAMEA is expected to grow at a CAGR of 11.9% from 2018 to 2025.

North America accounted for more than 40% share of the global market in 2017, and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidence of cancer, growth in geriatric population, and adoption of biochips due to their wide applications. In addition, presence of high number of key players and availability of sophisticated healthcare infrastructure are expected to offer new growth opportunities to the market players in future.
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll